2 nd line and recent ARVs prices and access issues Carmen Pérez Casas Access Campaign MSF May 2006.
Country presentation - Kenya Dr. Philip Owiti AMPATH, Kenya.
ARVs do not get rid of HIV from the body – they stop the production of virus!
Cross-sectional assessment of patient outcomes using a systematic file review process Ambereen Jaffer, Gesine Meyer-Rath, Malebo Maponyane, Aimee Malingan,
The Impact of HIV and AIDS on Education MTT 2004 Annual Winter School Mitigating the Impacts of HIV/AIDS on Education Systems Durban, 9 th August 2004.
Evaluation of quality and interchangeability of medicinal products Training workshop for evaluators from National Medicines Regulatory Authorities in East.
Humphrey Shao MD, MHS. Goals of ART Eradication of HIV? Not possible with currently available ARV medications.
PROGRESS & MAIN CHALLENGES IN TB DRUG R&D Martina Casenghi, PhD Biologist Expert consultation Geneva 11 Apr 2008.
Antiretroviral Resistance Testing in the Management of HIV-infected Patients Christopher Behrens, MD Amy Kindrick, MD Robert Harrington, MD.
Addressing Innovation and Access Through Voluntary Licensing: The Medicines Patent Pool Chan Park Washington, D.C. 25 July 2012.
Track E: Rapporteur Summary Pierre Barker. Track E: Rapporteur Summary Role of health systems in providing high quality care to all who need it The financing.